ECGS yields 2000.00% · ABBV yields 3.06%● Live data
📍 ECGS pulled ahead of the other in Year 1
Combined, ECGS + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECGS + ABBV for your $10,000?
Falcon Technologies, Inc. provides various design-build infrastructure services. The company offers telecommunications and data infrastructure services, which include communications infrastructure services to commercial, government, and other business enterprises. It also provides engineering services, program management, construction, installation and maintenance services, premise wiring services, tower and radio infrastructure services, and technology implementation and integration services, as well as a portfolio of infrastructure engineering and construction services. In addition, it offers design/build, installation, and maintenance services for electrical systems in factories, offices, healthcare facilities, government bases, and installations; and cell-phone relay towers, as well as sells electrical equipment, such as light fixtures, switchgear/panels, and fire alarm and control systems. Further, the company undertakes fire protection contracts in Northern California to provides layout and installation of various types of fire sprinkler systems, including wet and dry pipe, pre-action, in-rack, and fire pump systems in various commercial and industrial applications in new corporate headquarters, shopping centers, multi-tenant buildings, hospitals, nursing facilities, schools, and churches. Additionally, it offers emergency fire protection services with a fleet of approximately 25 service trucks. The company serves commercial builders/developers, government contractors, federal and state governments, education sector, and city/county. Falcon Technologies, Inc. is based in Rancho Cordova, California.
Full ECGS Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.